Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-01-03 @ 10:36 PM
Study NCT ID:
NCT06109558
Status:
RECRUITING
Last Update Posted:
2024-05-30
First Post:
2023-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC
Sponsor:
Hunan Province Tumor Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2023049
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None